Amicus Therapeutics Inc’s recently made public that its President and CEO Campbell Bradley L unloaded Company’s shares for reported $75124.0 on Dec 02 ’24. In the deal valued at $10.02 per share,7,500 shares were sold. As a result of this transaction, Campbell Bradley L now holds 886,654 shares worth roughly $8.77 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, BRADLEY CAMPBELL bought 7,500 shares, generating $74,850 in total proceeds.
Before that, Campbell Bradley L sold 7,901 shares. Amicus Therapeutics Inc shares valued at $98,800 were divested by the President and CEO at a price of $12.50 per share. As a result of the transaction, Campbell Bradley L now holds 886,654 shares, worth roughly $8.77 million.
Morgan Stanley downgraded its Amicus Therapeutics Inc [FOLD] rating to an Equal-weight from a an Overweight in a research note published on December 13, 2024; the price target was decreased to $12 from $17. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in early September with a ‘”a Buy”‘ rating. Wells Fargo began covering FOLD with “an Overweight” recommendation on May 30, 2024. Guggenheim revised its rating on May 14, 2024. It rated FOLD as “a Buy” which previously was an “a Neutral”.
Price Performance Review of FOLD
On Tuesday, Amicus Therapeutics Inc [NASDAQ:FOLD] saw its stock fall -0.10% to $9.89. Over the last five days, the stock has lost -2.37%. Amicus Therapeutics Inc shares have fallen nearly -30.30% since the year began. Nevertheless, the stocks have fallen -22.25% over the past one year. While a 52-week high of $14.57 was reached on 01/02/24, a 52-week low of $9.02 was recorded on 05/13/24. SMA at 50 days reached $10.51, while 200 days put it at $10.68.
Levels Of Support And Resistance For FOLD Stock
The 24-hour chart illustrates a support level at 9.75, which if violated will result in even more drops to 9.61. On the upside, there is a resistance level at 10.00. A further resistance level may holdings at 10.11. The Relative Strength Index (RSI) on the 14-day chart is 46.27, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.17, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 43.06%. Stochastics %K at 40.32% indicates the stock is a holding.
How much short interest is there in Amicus Therapeutics Inc?
A steep rise in short interest was recorded in Amicus Therapeutics Inc stocks on 2024-11-29, growing by 0.93 million shares to a total of 20.83 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 19.9 million shares. There was a rise of 4.46%, which implies that there is a positive sentiment for the stock.
